Disclosure Of Fair Value Measurement [Text Block]

ABIVAX - Filing #5984181

Concept	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Disclosure of fair value measurement [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets	—	—	—	—	—	205 228 EUR	—	327 062 EUR	—	—	—	—	—	—	75 544 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity	262 637 EUR	478 905 EUR	633,000 EUR	75,000 EUR	40 584 EUR	40 584 EUR	176 242 EUR	196 010 EUR	135 209 EUR	147 740 EUR	478 218 EUR	629,000 EUR	112,000 EUR	196 010 EUR	7 189 EUR	82 770 EUR	60 740 EUR	150 476 EUR	223,000 EUR	— EUR	7 189 EUR	42 452 EUR	25 934 EUR	39 361 EUR	107 578 EUR	— EUR	168,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]